Literature DB >> 11469506

In vitro metabolism of 14C-moxidectin by hepatic microsomes from various species.

J Dupuy1, E Escudero, C Eeckhoutte, J F Sutra, P Galtier, M Alvinerie.   

Abstract

Moxidectin is an antiparasitic drug widely used in cattle, sheep and companion animals. No data were available on its metabolism in wild species or in monogastrics. The in vitro metabolism of 14C-moxidectin was studied using hepatic microsomes from several different species: cow (Bos taurus). sheep (Ovis ovis), goat (Capra hircus), deer (Cervus dama), rat (Rattus norvegicus), pig (Sus scrofa and rabbit (Oryctolagus cuniculus). After separation and quantification by HPLC, the extent of metabolism of 14C-moxidectin was greatest with microsomes from sheep (32.7%) as compared to those from cows (20.6%), deer (15.4%), goats (12.7%). rabbits (7.0%) or rats (3.0%). The least metabolism occurred with microsomes from pigs. with 0.8% of total detected metabolites. A C29 monohydroxymethyl metabolite was detected in the greatest amounts. providing 0.4% out of the total detected radioactivity in pigs and 19.3% in sheep. In addition, the importance of P450 3A in the metabolism of 14C-moxidectin was confirmed by using in vivo induced P450 in combination with various P450 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469506     DOI: 10.1023/a:1010686508307

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  13 in total

1.  Ontogenic development of liver progesterone metabolism in female sheep. Contribution of cytochrome P4502B and P4503A subfamilies.

Authors:  M Kaddouri; N Brasset; M Alvinerie; C Eeckhoutte; C Bonfils; J Derancourt; P Galtier
Journal:  J Steroid Biochem Mol Biol       Date:  1992-06       Impact factor: 4.292

Review 2.  Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents.

Authors:  M Murray; G F Reidy
Journal:  Pharmacol Rev       Date:  1990-06       Impact factor: 25.468

Review 3.  Comparative in vivo and in vitro metabolism of ivermectin in steers, sheep, swine, and rat.

Authors:  S H Chiu; R Taub; E Sestokas; A Y Lu; T A Jacob
Journal:  Drug Metab Rev       Date:  1987       Impact factor: 4.518

4.  Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes.

Authors:  Z Zeng; N W Andrew; B H Arison; D Luffer-Atlas; R W Wang
Journal:  Xenobiotica       Date:  1998-03       Impact factor: 1.908

5.  The metabolism of avermectin-H2B1a and -H2B1b by pig liver microsomes.

Authors:  S H Chiu; E Sestokas; R Taub; J L Smith; B Arison; A Y Lu
Journal:  Drug Metab Dispos       Date:  1984 Jul-Aug       Impact factor: 3.922

Review 6.  Inhibitors of Cytochrome P-450s and their mechanism of action.

Authors:  B Testa; P Jenner
Journal:  Drug Metab Rev       Date:  1981       Impact factor: 4.518

7.  Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection.

Authors:  M Alvinerie; J F Sutra; M Badri; P Galtier
Journal:  J Chromatogr B Biomed Appl       Date:  1995-12-01

8.  The metabolism of avermectins B1a, H2B1a, and H2B1b by liver microsomes.

Authors:  G T Miwa; J S Walsh; W J VandenHeuvel; B Arison; E Sestokas; R Buhs; A Rosegay; S Avermitilis; A Y Lu; M A Walsh; R W Walker; R Taub; T A Jacob
Journal:  Drug Metab Dispos       Date:  1982 May-Jun       Impact factor: 3.922

9.  Milbemycins, a new family of macrolide antibiotics. Structure determination of milbemycins D, E, F, G, H, J and K.

Authors:  H Mishima; J Ide; S Muramatsu; M Ono
Journal:  J Antibiot (Tokyo)       Date:  1983-08       Impact factor: 2.649

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  7 in total

1.  The influence of parasitism on the pharmacokinetics of moxidectin in lambs.

Authors:  Anne Lespine; Jean-François Sutra; Jacques Dupuy; Michel Alvinerie; Gilles Aumont
Journal:  Parasitol Res       Date:  2004-05-01       Impact factor: 2.289

2.  Use of selamectin and moxidectin in the treatment of mouse fur mites.

Authors:  Deborah M Mook; Kimberly A Benjamin
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

Review 3.  Moxidectin and the avermectins: Consanguinity but not identity.

Authors:  Roger Prichard; Cécile Ménez; Anne Lespine
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

4.  DNA elements for constitutive androstane receptor- and pregnane X receptor-mediated regulation of bovine CYP3A28 gene.

Authors:  Mery Giantin; Jenni Küblbeck; Vanessa Zancanella; Viktoria Prantner; Fabiana Sansonetti; Axel Schoeniger; Roberta Tolosi; Giorgia Guerra; Silvia Da Ros; Mauro Dacasto; Paavo Honkakoski
Journal:  PLoS One       Date:  2019-03-25       Impact factor: 3.240

5.  Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle.

Authors:  Mery Giantin; Minna Rahnasto-Rilla; Roberta Tolosi; Lorena Lucatello; Marianna Pauletto; Giorgia Guerra; Francesca Pezzato; Rosa M Lopparelli; Roberta Merlanti; Paolo Carnier; Francesca Capolongo; Paavo Honkakoski; Mauro Dacasto
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

6.  Transgenic Expression of Haemonchus contortus Cytochrome P450 Hco-cyp-13A11 Decreases Susceptibility to Particular but Not All Macrocyclic Lactones in the Model Organism Caenorhabditis elegans.

Authors:  Natalie Jakobs; Esra Yilmaz; Jürgen Krücken
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

7.  Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.

Authors:  Beesan Tan; Nicholas Opoku; Simon K Attah; Kwablah Awadzi; Annette C Kuesel; Janis Lazdins-Helds; Craig Rayner; Victoria Ryg-Cornejo; Mark Sullivan; Lawrence Fleckenstein
Journal:  PLoS Negl Trop Dis       Date:  2022-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.